Twenty-five children with eyelid haemangiomas were reviewed. Fifteen patients with enlarging lesions thought to be at risk of causing amblyopia were treated with intralesional steroids as soon after presentation as possible. This appeared to reduce significantly the incidence of amblyopia. Surgery was reserved for older children in whom no further involution of the lesion was expected. Treatment was thought to be warranted if the lesion threatened the visual axis or if there were signs suggesting amblyopia (strabismus or refractive error). In accordance with their severity some lesions were followed up expectantly; the children were refracted and treated with glasses and occlusion therapy as necessary. Other children, in whom amblyopia was a greater risk, received steroid injections. The routine injection consisted of 40 mg of methylprednisolone and 4 mg of dexamethasone sodium phosphate. The first was injected directly into the lesion, and the second, more soluble, was injected paralesionally. The direct intralesional injection was given deeply to prevent long-acting depotsteroid deposits from being visible under the skin. The paralesional injection was given subcutaneously round the periphery of the haemangioma. The injections were repeated three times at approximately sixweek intervals if there was some response but no gross decrease in the size of the lesion. Two patients had a total of four injections each.
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Surgery consisted of lid debulking or adjusting lid height or contour and was done only after the tumour had passed into an inactive growth phase, usually after the age of six. Twenty two patients presented to us without any previous treatment, but three had initially undergone treatment elsewhere: one had a course of cryotherapy followed by one course of steroid injection; one had had two courses of cryotherapy; and one arrived with ptosis after surgical excision.
Results
Of the 25 patients 15 needed occlusion treatment, nine required glasses, and 15 had intralesional steroids. Of those not treated with steroids six had presented prior to its usage, two were children with lesions not warranting injections (too small or thought not to be at risk of causing amblyopia) and two presented after the active growth phase of the tumour had ended.
Twelve of the 15 (80%) required only one or two injections, but one case needed three and another two needed four. The injections often initially caused some extravasation of blood. The patients were reviewed after four weeks when any haematoma had absorbed. A subjective assessment was made by asking the parents if they thought the lesion had regressed, and an objective assessment was made by measuring the major and minor axes of the lesion. The injections had a significant reducing effect in nine of 15 (60%) cases ( Figs 1A, B) , questionable effect in four, and little or no effect in two (Figs 2). In those cases that responded there was a considerable reduction in subcutaneous vascularity as well as a reduction in bulk, but this was not easy to quantify. If subjectively and objectively there was a dramatic response, the injection was not repeated, but if there was only a partial improve- (Fig 3) . Although it was not possible to measure the lesions accurately, it was noted that, if the lesion was near the eyelid margin and the visual axis was threatened or occluded, amblyopia was common. We did not field that earlier injections gave better visual results than the later ones. The most amblyopic cases in the injected groups included both a child who had been injected at the earliest age (2 months) with an end vision of hand movements and the child who had been injected at the latest Figure Six children had a total of eight operations at a mean age of 7½yearss to correct the residual bulk of the lesion, entropion, ectropion, or ptosis. Five operations were debunking procedures via an anterior skin approach (with one including an anterior lid repositioning); one was a full-thickness lid resection (Fig 4) , another was a ptosis repair (anterior levator resection), and the remaining operation was a skin crease reformation procedure. Postoperatively the results were satisfactory, though in two cases the skin crease was not exactly symmetrical and the ptosis was slightly overcorrected in one case and undercorrected in another. 
Discussion

